Daratumumab,Talquetamab,Teclistamab,Pomalidomide
Genmab,Janssen
['mmsm']
aa3/ rr: 81%, for the tal 0.8 qow mdor, mpfs were 20 and 19 months; respectively. 12 months os was 91% #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter